Valley National Advisers Inc. Has $552,000 Stock Position in iShares Biotechnology ETF (NASDAQ:IBB)

Valley National Advisers Inc. raised its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 10.4% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 4,182 shares of the financial services provider’s stock after buying an additional 394 shares during the quarter. Valley National Advisers Inc.’s holdings in iShares Biotechnology ETF were worth $552,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of the business. BNP Paribas Financial Markets lifted its position in shares of iShares Biotechnology ETF by 29.3% during the 3rd quarter. BNP Paribas Financial Markets now owns 2,380,229 shares of the financial services provider’s stock valued at $346,561,000 after acquiring an additional 538,899 shares during the period. Commerce Bank increased its stake in iShares Biotechnology ETF by 1.8% in the third quarter. Commerce Bank now owns 743,366 shares of the financial services provider’s stock valued at $108,234,000 after purchasing an additional 12,921 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund raised its holdings in shares of iShares Biotechnology ETF by 32.9% during the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock valued at $96,533,000 after purchasing an additional 164,000 shares during the period. Main Management ETF Advisors LLC raised its holdings in shares of iShares Biotechnology ETF by 2.5% during the third quarter. Main Management ETF Advisors LLC now owns 593,370 shares of the financial services provider’s stock valued at $86,395,000 after purchasing an additional 14,535 shares during the period. Finally, Aprio Wealth Management LLC bought a new position in shares of iShares Biotechnology ETF during the 4th quarter worth about $18,476,000. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Stock Down 0.2 %

Shares of iShares Biotechnology ETF stock opened at $138.66 on Monday. The business has a 50-day simple moving average of $136.37 and a 200 day simple moving average of $141.55. iShares Biotechnology ETF has a one year low of $123.60 and a one year high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The company also recently disclosed a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were issued a dividend of $0.0624 per share. The ex-dividend date of this dividend was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.